This inventor holds 1 USPTO granted patent. Top assignee: Technology Resources International Corporation. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Stanklav Jn Shanurin: Innovator in Immunostimulatory Peptides
Introduction
Stanklav Jn Shanurin is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of immunology through his innovative research and development of peptides. His work focuses on enhancing immune responses, which is crucial for advancing medical treatments.
Latest Patents
Stanklav holds a patent for a hexapeptide known as Phe--Leu--Gly--Phe--Pro--Thr. This hexapeptide, derived from a myelopeptide, exhibits immunostimulatory activity when administered to mammals. This groundbreaking discovery has the potential to impact therapeutic approaches in immunology.
Career Highlights
Stanklav is associated with Technology Resources International Corporation, where he applies his expertise in peptide research. His work at the company has allowed him to explore various applications of his inventions in the medical field. With a patent portfolio that includes 1 patent, he continues to push the boundaries of scientific innovation.
Collaborations
Stanklav collaborates with talented individuals such as Rem V Petrov and Agusta A Mikhatlova. These partnerships enhance the research environment and foster the development of new ideas and technologies.
Conclusion
Stanklav Jn Shanurin is a prominent figure in the field of immunology, with a focus on peptide innovation. His contributions, particularly in the development of immunostimulatory peptides, are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile